Fresenius | FRE - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
Akzo Nobel EUR 4.88B 222M 2026-03
Alcon AG USD 22.13B 99M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
BASF EUR 33.2B 434M 2025-12
Bayer EUR 28.85B 2.9B 2026-03
Beiersdorf EUR 8.6B 133M 2025-12
DaVita Healthcare Partners USD -755.5M 104.41M 2026-03
Demant DKK 9.84B 446M 2025-12
E.ON EUR 28.83B 9.57B 2026-03
Essilor EUR 38.89B 1.07B 2025-12
Fresenius EUR 19.77B 1.14B 2025-12
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Getinge SEK 33.01B 2.75B 2024-12
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GN Store Nord DKK 10.12B 4.76B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Merck EUR 29.74B 1.15B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Philips EUR 11.39B 403M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
RWE EUR 41.56B 3.9B 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Smith & Nephew USD 5.54B 331M 2025-12